Sindel A, et al. Marginal zone lymphoma: state-of-the-art treatment. Curr Treat Options Oncol. 2019;20(12):90. https://doi.org/10.1007/s11864-019-0687-5.

Article  PubMed  Google Scholar 

Xochelli A, et al. Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity? Blood. 2014;123(8):1199–206. https://doi.org/10.1182/blood-2013-07-515155.

Article  CAS  PubMed  Google Scholar 

Akamatsu T, et al. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Helicobacter. 2006;11(2):86–95. https://doi.org/10.1111/j.1523-5378.2006.00382.x.

Article  PubMed  Google Scholar 

Chanudet E, et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol. 2006;209(3):344–51. https://doi.org/10.1002/path.1984.

Article  CAS  PubMed  Google Scholar 

Cerroni L, et al. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol. 1997;24(8):457–61. https://doi.org/10.1111/j.1600-0560.1997.tb01318.x.

Article  CAS  PubMed  Google Scholar 

Perrone S, et al. Infectious aetiology of marginal zone lymphoma and role of anti-infective therapy. Mediterr J Hematol Infect Dis. 2016;8(1):e2016006. https://doi.org/10.4084/mjhid.2016.006.

Article  PubMed  PubMed Central  Google Scholar 

Arcaini L, et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol. 2007;18(2):346–50. https://doi.org/10.1093/annonc/mdl388.

Article  CAS  PubMed  Google Scholar 

Smedby KE, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006;98(1):51–60. https://doi.org/10.1093/jnci/djj004.

Article  PubMed  Google Scholar 

Thieblemont C, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002;87(1):105–11. https://doi.org/10.1210/jcem.87.1.8156.

Article  CAS  PubMed  Google Scholar 

Royer B, et al. Lymphomas in patients with Sjogren’s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997;90(2):766–75.

Article  CAS  PubMed  Google Scholar 

Flospergher E, et al. Primary central nervous system marginal zone lymphoma. Br J Haematol. 2024;204(1):31–44. https://doi.org/10.1111/bjh.19238.

Article  CAS  PubMed  Google Scholar 

Liu L, et al. Splenic marginal zone lymphoma: a population-based study on the 2001–2008 incidence and survival in the United States. Leuk Lymphoma. 2013;54(7):1380–6. https://doi.org/10.3109/10428194.2012.743655.

Article  PubMed  Google Scholar 

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997;89(11):3909–18.

Camacho FI, et al. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol. 2001;25(10):1268–76. https://doi.org/10.1097/00000478-200110000-00007.

Article  CAS  PubMed  Google Scholar 

Chacón JI, et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood. 2002;100(5):1648–54.

Article  PubMed  Google Scholar 

Berger F, et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood. 2000;95(6):1950–6.

Article  CAS  PubMed  Google Scholar 

Thieblemont C, et al. Splenic marginal zone lymphoma: current knowledge and future directions. Oncology (Williston Park). 2012;26(2):194–202.

PubMed  Google Scholar 

Starr AG, et al. Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes. Br J Haematol. 2016;173(3):404–12. https://doi.org/10.1111/bjh.13975.

Article  CAS  PubMed  Google Scholar 

Du MQ. MALT lymphoma: A paradigm of NF-κB dysregulation. Semin Cancer Biol. 2016;39:49–60. https://doi.org/10.1016/j.semcancer.2016.07.003.

Article  CAS  PubMed  Google Scholar 

Ekström Smedby K, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029–38. https://doi.org/10.1182/blood-2007-10-119974.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brynes RK, et al. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. Mod Pathol. 1996;9(10):995–1000.

CAS  PubMed  Google Scholar 

Wotherspoon AC, et al. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood. 1995;85(8):2000–4.

Article  CAS  PubMed  Google Scholar 

Murga Penas EM, et al. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia. 2003;17(11):2225–9. https://doi.org/10.1038/sj.leu.2403122.

Article  CAS  PubMed  Google Scholar 

Rosebeck S, et al. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation. Science. 2011;331(6016):468–72. https://doi.org/10.1126/science.1198946.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanchez-Izquierdo D, et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood. 2003;101(11):4539–46. https://doi.org/10.1182/blood-2002-10-3236.

Article  CAS  PubMed  Google Scholar 

Afonina IS, et al. MALT1–a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression. Febs j. 2015;282(17):3286–97. https://doi.org/10.1111/febs.13325.

Article  CAS  PubMed  Google Scholar 

van Keimpema M, et al. FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells. Blood. 2014;124(23):3431–40. https://doi.org/10.1182/blood-2014-01-553412.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ye H, et al. High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood. 2003;101(7):2547–50. https://doi.org/10.1182/blood-2002-10-3167.

Article  CAS  PubMed  Google Scholar 

Streubel B, et al. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia. 2005;19(4):652–8. https://doi.org/10.1038/sj.leu.2403644.

Article  CAS  PubMed  Google Scholar 

Sagaert X, et al. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol. 2006;24(16):2490–7. https://doi.org/10.1200/jco.2006.05.6150.

Article  CAS  PubMed  Google Scholar 

Schreuder MI, et al. Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma. J Hematop. 2017;10(3–4):91–107. https://doi.org/10.1007/s12308-017-0302-2.

Article  PubMed